{"name":"The Taub Group","slug":"the-taub-group","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Scopolamine and naltrexone","genericName":"Scopolamine and naltrexone","slug":"scopolamine-and-naltrexone","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Scopolamine and naltrexone","genericName":"Scopolamine and naltrexone","slug":"scopolamine-and-naltrexone","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxQYm1ENHNjNWxoWTh5eVhWLVFXMlNEX0JHNTBUMnNrRmN0MzFFd043WkRiazdoSDlsRVppdDhBM3Q1Vl9oZ1JWdkUtTzdWeWtLQzZKOG1EZUFaRjNGNzFVeHVCc1ZPQlQ0ZHZiZ1hVZWgyQkJ3aEllUzJfZ0Zlc245VGxHdmVralFiem1BM05GRjRyeHd4d0N3ZA?oc=5","date":"2024-10-07","type":"trial","source":"Endpoints News","summary":"Special report 2024: Meet 20 women breaking new ground in biopharma R&D - Endpoints News","headline":"Special report 2024: Meet 20 women breaking new ground in biopharma R&D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTFBnQnByV1hWT0lNOXJ3UVk0TUNMb1dqT1RJd3E0c3lpbmdLTlBkQzBxU3ZPYmFjTDFEMWd1ZTBHbzI4T1VpQmhPcmE1U0xFVXFpbVZXbTNiU2VJVjFPTWxPZ2YyUlFYb0EwRnpzUWthMWZxRTBibXAwU25xSHo3QQ?oc=5","date":"2024-03-15","type":"pipeline","source":"pharmaphorum","summary":"Madrigal Pharma is first over the MASH finish line - pharmaphorum","headline":"Madrigal Pharma is first over the MASH finish line","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxOb3ZoMHNrVWFyVDl4UVJhVS1rRTNPd2xuM2VMcXB6VTBwd0dvbGhvTnpfMmpJRjRtMmpia01IMkJMc0ZuUlUyT0xNX0QxTllTQXNzMWJ3MUxNN0taeVVpcnpkMEJzVXhLdF90U3d1N2dpZ3RPOFVvcTlxQ21JZ2dnU2ptSERHZ0NHa3VBcVoyREY1VHlDSm5MNFp2Rm51czJBYmFVV1VncE91YmFDbmNQZFU0SFNEUmxUejAzZXlfZEs?oc=5","date":"2024-03-15","type":"regulatory","source":"Investopedia","summary":"Madrigal Pharmaceuticals Soars After Getting FDA Approval for Liver-Scarring Treatment - Investopedia","headline":"Madrigal Pharmaceuticals Soars After Getting FDA Approval for Liver-Scarring Treatment","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTE1NU1IxbGxDcUxneVlnNnFBTTJ4NkJjNFdHWVN6Vms5emxCaHVUUWxEUWJjb0J1Q3g3ZTFzTmVQS1BTRVFRWXRNTmxUYVVqZnJoTEgwODU4amdUT1pEVzBSbXRLVlJKRHRYRjRacjBxbDBodw?oc=5","date":"2024-03-14","type":"regulatory","source":"statnews.com","summary":"Madrigal wins first U.S. approval for drug to treat liver disease MASH - statnews.com","headline":"Madrigal wins first U.S. approval for drug to treat liver disease MASH","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE9Vc0ZwdzZMbVlsY0ZjeU5pWTZ0Sy1LNk45RVJnLWoyS3JxZkstY2l3a1FYeVVVSzBUcnoxbHNTNDNKUmR1WWRtOENySURkNW1oaHJlLVNQdmJIWW12Ykl5bw?oc=5","date":"2024-02-07","type":"trial","source":"NEJM","summary":"A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis - NEJM","headline":"A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxNbTJkTkgyem5uZm1qaVhVWVhES29SWkl3MlA0bHJZcGxjWnpZZEx1NWhLQUxhNWhJaUxPRzkxUHRMNHUxRUNzeS1tNVBiR0p6UnZBRlhjMzdnQk1rX3lZbklUNHpQMTMxNXRMMkdlNlNQbnRBSGU5dnp5YXlidHJUVDhnbw?oc=5","date":"2023-10-02","type":"pipeline","source":"Fierce Pharma","summary":"Fierce 50: Breakthroughs honorees - Fierce Pharma","headline":"Fierce 50: Breakthroughs honorees","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9AFBVV95cUxQSHNiMzJqeW92bW1PSVZfS1VjMXVJY09QYno3UER2aUN1X2sxNVVNY3BYeVVCdFNiQXBCeEFHa1Fyak5Xd1lQQUwyRk9tWTZUdHYxNmw5cFRqU0dMeHBUWFVkSy0tMDNSSGlBT3ltWHBFWXNfN1ZTa3lYZUtjcmV4NFJTakhaTjZKSlhHczdhTjU2WjF4VUY2VHBsQnRlU2NXWG5vcHZlRm94bFB2VUR5R3ZOUUlOcnhhejR6ekRxUV85ZzhrYlRDWS1rU2xhVUE5SU15cTUtbkRaaFdSel9yVldTUzFrOFFxd0wzQm5kZlRwc3VO?oc=5","date":"2022-03-04","type":"pipeline","source":"Post and Courier","summary":"SC agency rakes in millions from pharma company it regulates - Post and Courier","headline":"SC agency rakes in millions from pharma company it regulates","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxNZ0xLOERuNU5wR0o5MDNZMlFjbHMyNzlkcFpyUUpDQXlLdE9PVXM5X01Cd2V3NDFuRlZFQ1lySF85NmlWUTlHZE5jODc4REpQRFl3empWWDBGem1QcGVkd3BMcXdRb3NKdkVqaWV5SktuRXFHbUltM0ltSk00Q3A0N3dlSVpGaTBfampTR0RJcVJkRUFWQVBDbkU2dlJXNXY5d1RnODI2OEY5dFFDQ1E?oc=5","date":"2019-12-13","type":"pipeline","source":"The Business Journals","summary":"Madrigal Pharmaceuticals investor selling large chunk of its stake - The Business Journals","headline":"Madrigal Pharmaceuticals investor selling large chunk of its stake","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQd0hRSFNyLWtRcEtFMk5QWmZZTGFkTnNoVzlhUWl6ZTQweTVGV2pZZUFkaXVwQV9RcWFwbzZmYTVib25ldElUQUYxY3Fhdlg0TTFfc2ZvdmFrUEJhaTNSUmRoTHpaUkE5VVhScm1TeGxvRHgwV1h4YUlLVm1wakNKWnBIVFUzdVNZUDNTRmVJTQ?oc=5","date":"2017-10-10","type":"pipeline","source":"Life Science Leader","summary":"Companies To Watch: Madrigal Pharmaceuticals - Life Science Leader","headline":"Companies To Watch: Madrigal Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQOUtxMC1XSGZzZUVqd0JCR3FZeVpzLUpMWmlLc0tpcGtfQjJzS2lfclZfMW1zclBTLTJrXzlOcnY0X1k4RnQtQ0ZXNURfSndZZHQ3REhhUzZ3STB6ZWt0Z2VDV0VULXdFV0dVSVJfMTA2ekFTbE9WUmIzYVZzSTZTWnViclRFZ0FqLUdIR3NlYjg2THN6Q1praDFGVDlEUTBMUmFhVGFyZXFiM2ZXcVdn?oc=5","date":"2017-08-07","type":"pipeline","source":"Globes - Israel Business News","summary":"How we achieved Israel's biggest-ever pharma exit - Globes - Israel Business News","headline":"How we achieved Israel's biggest-ever pharma exit - Globes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPR2Q1MzE0STFCRVZwUF9BQ0tLSjdRTWpqdU5femRrZFg3LUJLSjlZN0hLQkZBNTdRMUFvck5GdEZVek01MTRMSEZrRG9sblBtbmV1LWlQOTlDMHFINkJYV0oxeWl0WEFURWlnOHNvdmpnSktnYlJ4OU03OGx1QTd4NWRHeFBKbHBuN25vc1NHaHNQd2vSAZgBQVVfeXFMUDdROGF2S3pPUElfRU13ZjJ5MjVubUJVUWROajRoejVsOWJoSDZmYS1qMlRvYklvUTlEcU9ENHJIeDdNNDhZTWJWaW4xS0NBZnFteXVzbVZuT1ozZWhvaklHXzRCdlJTckk5cDJZNndYVFRDYkZhdXAtaThLV2F6eDRDZlVfUU9rQ2JRQUNCQTlZMUszbW96a0s?oc=5","date":"2015-08-24","type":"pipeline","source":"timesofisrael.com","summary":"Pharmacy offers Arabs career boost, enhanced ties with Jews - timesofisrael.com","headline":"Pharmacy offers Arabs career boost, enhanced ties with Jews","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}